(2S,5R,6R)-6-({[3-(2-Chloro-6-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid(CAS: 5250-39-5)

Regulatory guidelines for this compound include the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations for European Union markets, and FDA/EPA requirements for pharmaceutical and environmental safety. Specific handling and disposal guidelines should comply with local and national regulations.

There are several alternatives and analogs that can be used in synthesis, such as similar oxazoles or other nitrogen-containing heterocycles. Common alternatives include isomers or reagents with similar functional groups, which can reduce the risk of certain hazards and simplify the synthesis process.

The market trend for this compound shows increasing demand in pharmaceutical and research applications due to its unique chemical structure. Research is focusing on its potential use as a drug candidate for various diseases, and price trends indicate stability with a growing demand in the pharmaceutical industry.

Waste containing this compound should be collected in a sealed, labeled container and disposed of through a professional waste disposal service. Incineration or other methods under environmental protection precautions are recommended, ensuring compliance with local and national regulations to minimize environmental impact.